Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1530, 2006-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raltitrexed + cisplatin beneficial for malignant pleural mesothelioma
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
Access to resources
Recommend
Pemetrexed/cisplatin worth it in malignant pleural mesothelioma
Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. :
Pemetrexed + cisplatin: first-line for malignant pleural mesothelioma
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
By Cutsem E.V.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. :
By de Cupis A. Semino C. Pirani P. Loprevite M. Ardizzoni A. Favoni R.E.
European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. :